DONATE

IBEC ERC grantee meets business angels

pauandxavierIBEC group leader and ICREA research professor Pau Gorostiza was one of nine ERC Proof of Concept holders to take part in the European Business Angel Network (EBAN) Winter University this week in Copenhagen.

Pau pitched his project, THERALIGHT: Therapeutic Applications of Light-Regulated Drugs, to the investors from all over the world at the event, which he attended alongside eight other awardees specially selected by the ERC. Together they made up nearly half of the 20 European start-ups hoping to catch the eye of an investor interested in exploring the innovation potential of their findings.

PhD Thesis defence: Ernest Moles

“Development of polyvalent erythrocyte- and parasitized erythrocyte-targeted nanovectors as novel site-specific drug delivery approaches for Plasmodium falciparum malaria chemotherapy”

PhD Thesis defence: Ernest Moles

“Development of polyvalent erythrocyte- and parasitized erythrocyte-targeted nanovectors as novel site-specific drug delivery approaches for Plasmodium falciparum malaria chemotherapy”